330 related articles for article (PubMed ID: 18330778)
1. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine for treatment-resistant unipolar depression.
Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith WT; Glaudin V; Panagides J; Gilvary E
Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
7. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
Mahapatra SN; Hackett D
Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic action lag time and resistance to treatment].
Peretti CS
Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
[TBL] [Abstract][Full Text] [Related]
9. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.
Entsuah AR; Rudolph RL; Chitra R
Psychopharmacol Bull; 1995; 31(4):759-66. PubMed ID: 8851650
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
Zajecka JM; Jeffries H; Fawcett J
J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
Mendels J; Johnston R; Mattes J; Riesenberg R
Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661
[TBL] [Abstract][Full Text] [Related]
14. New developments in the treatment of depression.
Montgomery SA
J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
[TBL] [Abstract][Full Text] [Related]
16. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Gründer G; Wetzel H; Schlösser R; Benkert O
Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of mianserin in moderately to severely depressed outpatients.
Carman JS; Ahdieh H; Wyatt-Knowles E; Warga E; Panagides J
Psychopharmacol Bull; 1991; 27(2):135-9. PubMed ID: 1924659
[TBL] [Abstract][Full Text] [Related]
18. Venlafaxine in the treatment of children and adolescents with major depression.
Mandoki MW; Tapia MR; Tapia MA; Sumner GS; Parker JL
Psychopharmacol Bull; 1997; 33(1):149-54. PubMed ID: 9133767
[TBL] [Abstract][Full Text] [Related]
19. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
Besançon G; Cousin R; Guitton B; Lavergne F
Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
[TBL] [Abstract][Full Text] [Related]
20. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Owen JR; Nemeroff CB
Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
